299,303 A randomized placebo-controlled trial with 18,353 participants aged 50 years and older (16,657 of whom had never had depression and 1,696 of whom had had depression but had not been treated for at least two years) found taking 2,000 IU vitamin D daily for a median of 5.3 years did not reduce the risk of developing depression or clinically relevant depressive symptoms
In consideration of the semaglutide-related GI AEs, treatment with GLP-1 RAs should begin with a structured dose-escalation schedule aimed at minimising these effects [64,65,66]
The duration of treatment may also play a role, with some evidence suggesting that longer treatment periods may be associated with better weight maintenance, though this relationship is not definitively established
Their aberrant activity, likely caused by mutation or altered expression levels, might contribute to pathogenesis of AR-related diseases
Ready for immediate dispatch